| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |